Endothelin antagonists in diabetic nephropathy: back to basics.
Department of Medicine and Division of Nephrology, and.
Kiran
K
Chandrashekar
Department of Medicine and Division of Nephrology, and Department of Physiology, University of Mississippi Medical Center, Jackson, Mississippi ljuncos@umc.edu.
Luis A
LA
Juncos
D000818:Animals; D002318:Cardiovascular Diseases / Q000097:blood* / Q000401:mortality*; D008076:Cholesterol, HDL / Q000097:blood*; D003928:Diabetic Nephropathies / Q000209:etiology*; D019332:Endothelin-1 / Q000502:physiology*; D005260:Female; D006801:Humans; D008297:Male; D050199:Podocytes / Q000378:metabolism* / Q000473:pathology*; D051436:Renal Insufficiency, Chronic / Q000097:blood* / Q000401:mortality*
D008076:Cholesterol, HDL; D019332:Endothelin-1
cell signaling; chronic kidney disease; diabetic; endothelin antagonists; glomerulosclerosis; nephropathy; podocyte